SE462419B - Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar - Google Patents

Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar

Info

Publication number
SE462419B
SE462419B SE8303700A SE8303700A SE462419B SE 462419 B SE462419 B SE 462419B SE 8303700 A SE8303700 A SE 8303700A SE 8303700 A SE8303700 A SE 8303700A SE 462419 B SE462419 B SE 462419B
Authority
SE
Sweden
Prior art keywords
hda
injection
animals
treatment
cardiovascular diseases
Prior art date
Application number
SE8303700A
Other languages
English (en)
Swedish (sv)
Other versions
SE8303700L (sv
SE8303700D0 (sv
Inventor
H Ohnishi
K Yamaguchi
Y Suzuki
N Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of SE8303700D0 publication Critical patent/SE8303700D0/xx
Publication of SE8303700L publication Critical patent/SE8303700L/xx
Publication of SE462419B publication Critical patent/SE462419B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D315/00—Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Basic Packing Technique (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8303700A 1982-06-28 1983-06-28 Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar SE462419B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57111183A JPS591415A (ja) 1982-06-28 1982-06-28 循環系疾患治療剤

Publications (3)

Publication Number Publication Date
SE8303700D0 SE8303700D0 (sv) 1983-06-28
SE8303700L SE8303700L (sv) 1983-12-29
SE462419B true SE462419B (sv) 1990-06-25

Family

ID=14554592

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303700A SE462419B (sv) 1982-06-28 1983-06-28 Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar

Country Status (11)

Country Link
US (1) US4578400A (Direct)
JP (1) JPS591415A (Direct)
AU (1) AU546935B2 (Direct)
CA (1) CA1209921A (Direct)
CH (1) CH660556A5 (Direct)
DE (1) DE3323264C2 (Direct)
FR (1) FR2529081B1 (Direct)
GB (1) GB2123691B (Direct)
IT (1) IT1173725B (Direct)
NL (1) NL187299C (Direct)
SE (1) SE462419B (Direct)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2665737B2 (ja) * 1986-05-27 1997-10-22 宇部興産株式会社 微粒子状無機フイラー分散液の製造法
CA2016467A1 (en) 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
IL110172A (en) * 1993-07-22 2001-10-31 Lilly Co Eli Bicyclic compounds and pharmaceutical compositions containing them
AU2003278212B2 (en) * 2002-07-31 2009-07-09 Centre National De La Recherche Scientifique Stem cells derived from adipous tissue and differentiated cells derived from said cells
CA2529367C (en) * 2003-06-18 2012-09-11 Institut De Cardiologie De Montreal/Montreal Heart Institute Preventing atrial fibrillation (af) with the use of statin drugs
DE102004052697A1 (de) * 2004-10-29 2006-05-04 Haehner, Thomas, Dr. Pharmazeutische Zubereitungen zur Behandlung von Folgen des Alkoholmissbrauchs, Hepatitis, Pankreatitis, Alzheimererkrankung, Morbus Parkinson, Diabetes, toxischen Nierenerkrankungen, Reperfusionsschäden, der Arteriosklerose sowie als Antidote gegen Umweltgifte und Medikamentenintoxikation
CN104188952A (zh) * 2005-03-02 2014-12-10 默沙东公司 抑制组织蛋白酶k的组合物
DE102006019906A1 (de) 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptable Salze zur Herstellung einer pharmazeutischen Zubereitung
JP5469781B1 (ja) * 2012-03-27 2014-04-16 辻本化学工業株式会社 ＰＰＡＲｓアゴニスト活性亢進薬
MX395356B (es) * 2017-04-10 2025-03-25 Vitaflo Int Ltd Composicion para usar en el tratamiento de la epilepsia.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1417119A (en) * 1972-11-30 1975-12-10 Thiele G H Process for treating bones
US4225501A (en) * 1977-07-25 1980-09-30 Givaudan Corporation 1,4-Epoxy-1,3,3-trimethyl-2-(2-buten-1-ylidene)-cyclohexanes
US4357315A (en) * 1980-08-07 1982-11-02 International Flavors & Fragrances Inc. Use of 1-ethoxy-1-ethanol acetate for augmenting or enhancing the taste of toothpaste

Also Published As

Publication number Publication date
NL8302273A (nl) 1984-01-16
AU1631583A (en) 1984-01-05
DE3323264C2 (de) 1986-03-06
IT1173725B (it) 1987-06-24
US4578400A (en) 1986-03-25
CH660556A5 (de) 1987-05-15
NL187299C (nl) 1991-08-16
SE8303700L (sv) 1983-12-29
IT8348588A0 (it) 1983-06-28
AU546935B2 (en) 1985-09-26
FR2529081B1 (fr) 1985-11-15
JPS591415A (ja) 1984-01-06
DE3323264A1 (de) 1984-01-05
JPH0142246B2 (Direct) 1989-09-11
IT8348588A1 (it) 1984-12-28
CA1209921A (en) 1986-08-19
GB2123691A (en) 1984-02-08
GB8317357D0 (en) 1983-07-27
SE8303700D0 (sv) 1983-06-28
NL187299B (nl) 1991-03-18
FR2529081A1 (fr) 1983-12-30
GB2123691B (en) 1985-07-31

Similar Documents

Publication Publication Date Title
US4613593A (en) Therapeutic and preventive agent containing dolichol
DE60005017T2 (de) Prodrugs von impdh-inhibierenden carbamaten
EP0324387B1 (en) Composition for treatment of ischemic disorder in organs
JPH02108636A (ja) 抗腫瘍性組合せ製剤
CN102369193A (zh) 缩醛磷脂化合物、包含缩醛磷脂化合物的药物组合物和用于治疗衰老性疾病的方法
SE462419B (sv) Terapeutisk komposition foer behandling av kardiovaskulaera sjukdomar
JP2002537258A5 (Direct)
FR2555050A1 (fr) Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine, utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
JP3183664B2 (ja) コレステロール及び胆汁酸の代謝阻害剤
WO2001003699A1 (de) Arzneimittel mit protektiver wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische substanzen
DE2923009A1 (de) Mittel zur prophylaxe und behandlung der fibrose
JP3075358B2 (ja) 肝機能改善剤
US4847297A (en) Use of penicillamine for treating immune damaging illnesses
JPS6117574A (ja) カルシウム拮抗活性のある１‐〔ビス‐（４‐ルオロフエニル）‐メチル〕‐４‐（３‐フエニル‐２‐プロペニル）‐ヘキサヒドロ‐１ｈ‐１，４‐ジアゼピンとその製法及びそれを含有する医薬組成物
EP0207097B1 (de) Neue kohlensäureester
US2890982A (en) Method of combatting helminthiasis using nitro-furyl-acrylate derivatives
US4603126A (en) Therapeutic and preventive agent containing dolichol
WO2012056976A1 (ja) アデニル酸シクラーゼの活性調節剤
EP0149847A2 (en) Therapeutic and preventive agent containing dolichol
US4791105A (en) Therapeutic and preventive agent containing dolichol
CH631713A5 (fr) Derives de chromones a activite medicamenteuse et leur preparation.
US4599328A (en) Therapeutic and preventive agent containing dolichol
EP0121856A2 (de) Verwendung von Pyrazolonderivaten bei der Bekämpfung des Wachstums von Tumorzellen und der Metastasenbildung, Arzneimittel hierfür und Verfahren zu deren Herstellung
JP3075360B2 (ja) コレステロール降下剤
DE3244806C2 (Direct)

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8303700-2

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8303700-2

Format of ref document f/p: F